As of February 2026, there is significant movement

New Post Public Reply Private Reply Replies (0) Message Board
biloxiblues biloxiblues #159864
564
As of February 2026, there is significant movement regarding Leronlimab and brain cancer, specifically glioblastoma (GBM). While it is not yet an FDA-approved "standard of care" for GBM, it has entered a more active phase of clinical and compassionate use.Here is the current landscape for Leronlimab and brain tumors:1. Investigator-Initiated Study (Recurrent GBM)Recent reports indicate that an investigator-initiated study for patients with recurrent glioblastoma is anticipated to begin in 2026. This study is expected to be supported by private funding and will likely focus on the mechanism identified in the research you mentioned—blocking the CCR5 receptor to stop the tumor's "fertilizer" (CCL5) and targeting glioma stem cells.2. Expanded Access (Compassionate Use)If you or someone you know is looking for immediate options, Expanded Access Programs (EAPs) are the most active "non-trial" route right now:Active Programs: CytoDyn (the manufacturer) recently secured funding to open an EAP specifically for advanced solid tumors. While the primary focus has been Triple-Negative Breast Cancer (TNBC) and Colorectal Cancer, the program is designed for patients who have exhausted other options.eIND Applications: Physicians can still apply for emergency Investigational New Drug (eIND) access. In 2025 and early 2026, several patients with aggressive solid tumors have successfully obtained Leronlimab through this "compassionate use" pathway when their tumors showed CCR5 activity.3. The "Prime and Pair" StrategyThe buzz in 2026 oncology circles is about using Leronlimab to convert "cold" tumors to "hot" tumors.Because glioblastoma is famously "cold" (it hides from the immune system), researchers are testing if Leronlimab can "prime" the tumor by blocking CCR5 and then "pair" it with an immune checkpoint inhibitor (like Keytruda).This is relevant for GBM because it could potentially make the tumor visible to the immune system for the first time.Summary of Status (Feb 2026)StatusDetailsClinical TrialInvestigator-initiated study for Recurrent GBM expected to start in 2026.Compassionate UseAvailable via eIND or the new 2026 Expanded Access Program.FDA StatusInvestigational (Not yet approved for GBM).ManufacturerCytoDyn Inc. (working with WEP Clinical as the clinical research partner).

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DAHON's Tech: Crafting Folders That Ride Like Road Bikes

Updated Category News Views 4

The Folding Bike Revolution: More Than Just a Fad You've seen them zipping around—those compact, folding bikes. They're not just for urban commuters looking to save space. Oh no, this is a full-blown cycling revolution we're talking about. DAHON, a name that's been rolling since 1982, has been riding these waves and making strides that others can only dream of. While...

Continue Reading
Arizona Voters Demand Clear Plans for 2026 Election

Updated Category News Views 3

A Shift in Voter Expectations: Clear Actions Needed Arizona voters have spoken, and they aren't looking for the same old political song and dance anymore. They crave something meatier—action, not just words. Heading into the 2026 general election, folks in the Grand Canyon State are demanding concrete solutions and straightforward answers from those who seek to lead...

Continue Reading
Debt Crisis Looms: Social Security at Risk

Updated Category News Views 4

Debt Reality: A National Concern with Global Implications When it comes to the U.S. federal debt situation, the latest report from the National Seniors Policy Center is lighting a fire like no other, warning us that we're not crying wolf here. We've got fiscal numbers that may not sit well at breakfast. With roughly 67 cents of every new buck Uncle Sam borrows going to...

Continue Reading
Menopause Policy Advocacy Takes Center Stage in DC

Updated Category News Views 5

Unlikely Spotlight on Menopause at Capitol Hill If you told me a couple of years back that menopause would become a front-page political issue, I would've laughed. Yet, here we are, with over 125 advocates from 29 states converging on Washington, D.C., demanding legislative action on menopause. Why Menopause Matters in Policy The fact that more than half the population is...

Continue Reading
Bellissima Bags Allure Award for Curly Hair Tool

Updated Category News Views 4

Award-Winning Tool Headlines 2026 Beauty Scene There's a shake-up in the world of hair tools, folks. Bellissima's Diffon Supreme has snagged a 2026 Allure Best of Beauty Award for its prowess in taming the curly, wavy, and coily strands we all crave to manage. Performance Meets Innovation in Bellissima's Latest Let's not beat around the bush. The Diffon Supreme's trump...

Continue Reading
Mental Health Day Celebrations Set for October in NYC

Updated Category News Views 7

Mental Health Steals the October Spotlight In the bustling streets of New York City, October is about to get a mental health makeover. Project Healthy Minds is putting the pedal to the metal with their fourth annual World Mental Health Day Gala on October 8th, followed by the world’s largest mental health festival on October 10th. These events, held at Spring Studios,...

Continue Reading
Ensuring Your Radon Mitigation System Stays Effective

Updated Category News Views 2

Radon Mitigation: A Critical Measure for Home Safety Homeowners, you're probably aware of the ticking health time bomb known as radon. Not just an annoying gas, this colorless, odorless beast lurks quietly, threatening family health if not managed right. Mitch Kelley, a specialist in radon testing with Basement Solutions in Mankato, Minnesota, lays out a no-fuss guide to...

Continue Reading
GenAI Boosts Grades and Tech Savvy for Online Learners

Updated Category News Views 3

What's Really Driving GenAI Use in Online Education? Let's not beat around the bush—most folks think students turn to this newfangled generative AI mainly to smooth over academic hurdles or save time. But guess what? The University of Phoenix has gone and poked some holes in that assumption. Study Highlights Key Insights This solid piece of research from the...

Continue Reading
Calavera NY Website Revamp: Gemstone Expansion Hits

Updated Category News Views 5

Calavera New York's Bold Online Makeover When a jewelry brand that's all about slashing retail markups makes a move this big, it's worth a real close-up look. Calavera New York, a name buzzing in the diamond and gemstone scene, just dropped a redesigned website that’s turning more than a few heads. They’re known for cutting out the middleman, a strategy that already...

Continue Reading
Invictus Pharmacy Secures LegitScript Certification Status

Updated Category News Views 2

A New Chapter for Invictus Pharmacy In a world tangled up in red tape, Invictus Pharmacy somehow managed to cut a clear path by earning the LegitScript Healthcare Merchant Certification. Now, it seems like they've joined the ranks of the big players, including the likes of Amazon Pharmacy. It’s not just a shiny badge on their website, folks. It’s better access to...

Continue Reading

Top 5 Most Recently Viewed Articles

Gordon Brothers Welcomes Atlantic RMS: A Powerful Merger

Updated Category News Views 205

Gordon Brothers Expands Services with Atlantic RMS Acquisition Gordon Brothers, renowned as global asset experts, is thrilled to announce its acquisition of Atlantic Risk Management Services (Atlantic RMS). This significant move marks a substantial expansion of its valuation and corporate recovery capabilities across the U.K. and Europe, particularly in accounts...

Continue Reading
Shell plc Announces Interim Dividend for Q3 2025

Updated Category News Views 287

Shell plc's Interim Dividend Announcement Shell plc, a significant player in the energy market, has recently declared an interim dividend for the third quarter of 2025. As part of its ongoing commitment to returning value to shareholders, the company set the dividend at US$ 0.358 per ordinary share. This decision reflects Shell's financial health and commitment to its...

Continue Reading
Bitcoin Surges as Global Markets React to Fed Rate Cuts

Updated Category News Views 70

Bitcoin Rises with Positive Market Trends Recently, Bitcoin has hit a three-week high, climbing 3.9%. The digital currency was trading at around $61,900, fueled by a notable upswing in US equity futures. This boost is tied to the Federal Reserve's choice to lower interest rates, hinting at a possible new phase of monetary easing. Effects of the Fed's Rate Decrease The...

Continue Reading
Seamless Therapeutics Welcomes Alvin Shih to Its Board

Updated Category News Views 142

Seamless Therapeutics Welcomes Alvin Shih to Its Board Seamless Therapeutics has recently announced the exciting appointment of Dr. Alvin Shih as an Independent Director on its Board. This strategic move comes as the company continues its mission to advance its innovative gene editing technologies, particularly in the realm of rare diseases. Dr. Shih's extensive...

Continue Reading
Nokia Corporation Reports Transactions in Senior Management

Updated Category News Views 202

Nokia Corporation Announces Recent Managerial Transactions Nokia Corporation has made headlines with its recent managerial transactions, specifically the acquisition involving Tommi Uitto, a senior manager within the company. This activity reflects ongoing developments at Nokia and showcases its commitment to fostering growth and engagement within its leadership. Overview...

Continue Reading